
Please try another search
LONDON - AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN), the UK-based biopharmaceutical company, has published its Annual Report and Form 20-F Information for the year 2024. The report, which details the...
LONDON - AstraZeneca PLC (LSE/STO/Nasdaq: LON:AZN), a global biopharmaceutical company, today announced upcoming changes to its board of directors. Karen Knudsen is set to be proposed for election as...
Investing.com -- UBS made key adjustments to its ratings on major European pharmaceutical companies, downgrading Novartis (SIX:NOVN) while upgrading Roche and AstraZeneca (NASDAQ:AZN) in notes on...
Investing.com - European pharmaceutical stocks offer solid growth, valuations near 10-year lows, and a possible safe haven from challenges related to U.S. President Donald Trump's tariff plans,...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review